FDA inspection
Rubicon Research Limited: FDA inspection ending Apr 11, 2013
FDA inspection 828916 · Voluntary Action Indicated (VAI) · Thane
Key facts
| Inspection ID | 828916 |
|---|---|
| Firm | Rubicon Research Limited |
| FEI number | 3008252295 |
| Address | Plot No K-30/4 & K30/5, Midc, Additional Ambernath Area |
| City | Thane |
| Country | India |
| Fiscal year | 2013 |
| Inspection end date | Apr 11, 2013 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data